SABSW
SAB Biotherapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.02
+0.43%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 1.01x
Trailing multiples
Trailing twelve months
- P/E TTM
- 0.01x
- PEG TTM
- —
- Price / book
- 0.00x
- Price / sales
- —
- Price / cash flow
- -0.00x
Enterprise value
- Enterprise value
- -$97.2M
- EV / sales
- —
- EV / EBITDA
- 10.28x
- EV / EBIT
- 1.35x
- Market cap
- $251.6K
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026